Insider Transactions in Q2 2024 at Chemed Corp (CHE)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 12
2024
|
Patrick P Grace |
SELL
Open market or private sale
|
Direct |
284
-7.99%
|
$153,360
$540.98 P/Share
|
Jun 06
2024
|
Kevin J Mcnamara president and CEO |
SELL
Open market or private sale
|
Direct |
1,500
-1.38%
|
$816,000
$544.17 P/Share
|
May 20
2024
|
George J Walsh Iii |
BUY
Grant, award, or other acquisition
|
Direct |
284
+7.23%
|
$160,176
$564.34 P/Share
|
May 20
2024
|
Thomas P Rice |
BUY
Grant, award, or other acquisition
|
Direct |
284
+4.5%
|
$160,176
$564.34 P/Share
|
May 20
2024
|
John Meredith Mount Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
284
+30.31%
|
$160,176
$564.34 P/Share
|
May 20
2024
|
Eileen P Mc Carthy |
BUY
Grant, award, or other acquisition
|
Direct |
284
+32.95%
|
$160,176
$564.34 P/Share
|
May 20
2024
|
Andrea R Lindell |
BUY
Grant, award, or other acquisition
|
Direct |
284
+4.15%
|
$160,176
$564.34 P/Share
|
May 20
2024
|
Christopher J Heaney |
BUY
Grant, award, or other acquisition
|
Direct |
284
+11.85%
|
$160,176
$564.34 P/Share
|
May 20
2024
|
Patrick P Grace |
BUY
Grant, award, or other acquisition
|
Direct |
284
+7.4%
|
$160,176
$564.34 P/Share
|
May 20
2024
|
Ron De Lyons |
BUY
Grant, award, or other acquisition
|
Direct |
284
+16.98%
|
$160,176
$564.34 P/Share
|
May 16
2024
|
Kevin J Mcnamara president and CEO |
SELL
Open market or private sale
|
Direct |
4,000
-3.55%
|
$2,268,000
$567.54 P/Share
|
May 07
2024
|
Michael D Witzeman VP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
921
-23.13%
|
$530,496
$576.95 P/Share
|
May 07
2024
|
Michael D Witzeman VP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+21.65%
|
$454,300
$413.19 P/Share
|
Apr 30
2024
|
Spencer S Lee executive vice president |
SELL
Bona fide gift
|
Direct |
1,133
-5.46%
|
-
|